YI.NASDAQ111, INC

SCHEDULE: 111, Inc. Faces Going-Private Proposal

Sentiment:

Consortium Agreement and Going-Private Proposal


Key stakeholders of 111, Inc. have submitted a non-binding proposal to acquire all outstanding Class A shares not currently owned by the consortium, aiming for a delisting from NASDAQ.

Capital raiseThe transaction will be funded by equity capital in the form of rollover equity from the consortium members (Dr. Gang Yu, Mr. Junling Liu, Sunny Bay Global Limited) and a cash contribution from A.Huadeng Tech BioArray Ventures Ltd.The Equity Contribution Schedule indicates a total cash contribution of US$20,690,000.0 from Huadeng Tech BioArray Ventures Ltd, representing 55.43% of the contemplated ownership.

Summary

  • A consortium including co-founders Dr. Gang Yu and Mr. Junling Liu, along with Sunny Bay Global Limited and A.Huadeng Tech BioArray Ventures Ltd, has entered into a consortium agreement to pursue a going-private transaction for 111, Inc.
  • The proposal outlines an acquisition of all Class A ordinary shares not owned by the consortium at a price of US$0.226 per share or US$4.52 per ADS.
  • This proposed price represents a 29.5% premium to the closing price on September 15, 2026, and a 20% premium over the average closing price for the preceding 60 trading days.
  • The transaction is structured as a merger where a newly formed entity, Holdco, will merge with 111, Inc., with 111, Inc. surviving as a private entity.
  • The consortium members, who collectively hold significant voting power through Class B shares, have agreed to vote in favor of the transaction and to work exclusively with each other during the negotiation period.
  • The transaction is not subject to any debt financing conditions, as it will be funded by rollover equity from the consortium members and cash contributions from A.Huadeng Tech BioArray Ventures Ltd.
  • A special committee of independent directors will be formed to review the proposal and make a recommendation to the board.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, indicating a serious intent to take the company private at a premium, though the transaction is still in its preliminary stages.

Positives

  • The proposed acquisition price of $0.226 per Class A share (or $4.52 per ADS) offers a significant premium to recent trading prices, providing a potential upside for shareholders.
  • The transaction is not contingent on debt financing, reducing the risk of financing-related delays or failures.
  • The consortium includes key company insiders (co-founders), suggesting a deep understanding of the business and a commitment to its continued operation.
  • The agreement establishes exclusivity among consortium members, streamlining the negotiation process and reducing the likelihood of competing bids.
  • The formation of a special committee with independent directors aims to ensure a fair review process for all shareholders.

Negatives

  • The proposal is preliminary and non-binding, with definitive agreements yet to be negotiated and executed.
  • The transaction is subject to the approval of the special committee and the board of directors, as well as other customary closing conditions.
  • The delisting from NASDAQ and deregistration under the Exchange Act will result in reduced public float and potentially less liquidity for remaining shareholders.
  • The consortium members' significant voting power through Class B shares could influence the outcome of the transaction.

Risks

  • Failure to agree on definitive documentation with the Special Committee.
  • Potential disagreements among consortium members regarding material terms of the transaction.
  • Regulatory approvals or other governmental requirements could delay or prevent the transaction.
  • The possibility that the Special Committee may not recommend the transaction to the board.
  • The risk that the company's board or special committee may not approve the proposed terms.
  • The transaction could be terminated if a party breaches the consortium agreement.

Future Outlook

The consortium intends to continue the company's business operations in a manner generally consistent with its current operations following the completion of the proposed transaction. The transaction is expected to result in the delisting of the Company's ADSs from NASDAQ and deregistration under the Exchange Act.

Management Comments

  • We are pleased to submit this preliminary non-binding proposal to acquire all outstanding Class A ordinary shares... in a going-private transaction at a purchase price of US$0.226 per Class A Share or US$4.52 per ADS.
  • Our proposed purchase price represents a premium of 29.5% to the closing price of the ADS on September 15, 2026... and a premium of 20% to the average closing price of the ADSs during the last 60 trading days...
  • We agree that the Company's board of directors should appoint a special committee of independent and disinterested directors to consider our proposed transaction and make a recommendation to the Board.
  • We will not move forward with the transaction unless it is approved by such special committee.
  • None of the Company's directors who are affiliated with us will participate in the consideration of our proposal by the Company, the special committee or the special committee's advisors.
  • We currently intend that following completion of the proposed transaction, the Company's business will continue to be run in a manner that is generally consistent with its current operations.
  • We expect that the merger agreement will provide for representations, warranties, covenants and conditions that are typical, customary and appropriate for transactions of this type.
  • We believe that our proposal represents an attractive opportunity for the Company's shareholders to receive a significant premium to the current and recent prices of the ADSs.

Industry Context

StockSavvy.ai notes that the trend of 'going private' transactions, particularly for companies listed on US exchanges but with significant operations in China, continues. These transactions are often driven by a desire to escape public market scrutiny, reduce compliance costs, and allow management more flexibility in strategic decision-making, especially when the market may not fully value the company's long-term potential.

Comparison to Industry Standards

  • The proposed premium of 29.5% over the last trading day's closing price and 20% over the 60-day average is within the typical range for going-private transactions, which often aim to provide a substantial incentive for shareholders to approve the deal.
  • The structure involving a consortium of founders and a sponsor is common in such transactions, allowing for shared risk and capital contribution.
  • The engagement of a special committee of independent directors and external advisors is a standard governance practice to ensure fairness in transactions involving controlling shareholders or insiders.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Special Committee FormationThe proposal anticipates the formation of a special committee comprised of independent directors to review and negotiate the transaction.Upon Board ApprovalEnhances fairness and oversight by ensuring independent review of the transaction.
Director RecusalDirectors affiliated with the consortium will not participate in the review or approval of the proposal.Upon Board ApprovalMitigates conflicts of interest and strengthens the independence of the review process.

Related Party Transactions

  • The proposed transaction is initiated by a consortium that includes the company's co-founders (Dr. Gang Yu and Mr. Junling Liu) and entities they are associated with (Sunny Bay Global Limited, wholly owned by Mr. Liu). This constitutes a related party transaction due to the insider status of the proposers.

Stakeholder Impact

  • Shareholders: Potential for a premium price for Class A shares, but also delisting from NASDAQ and reduced liquidity.
  • Employees: The business is expected to continue operations generally consistent with current practices, suggesting minimal immediate impact on employment, though future strategic shifts post-privatization are possible.
  • Management: Founders and key management involved in the consortium will transition from public company leadership to private company leadership.

Next Steps

  • The Company's board of directors is expected to form a special committee of independent directors.
  • The special committee will retain independent legal and financial advisors.
  • The consortium will engage in discussions and negotiations with the special committee regarding the terms of the definitive agreements.
  • Execution of definitive documentation, including a merger agreement.
  • Obtaining necessary approvals from the special committee, the board of directors, and potentially shareholders.
  • Completion of the transaction, leading to the delisting of the Company's ADSs from NASDAQ.

Key Dates

DateDescription
2026-09-16Date of the Consortium Agreement and the submission of the preliminary non-binding proposal.
2026-09-17Date of the Joint Filing Agreement for Schedule 13D.

Recommendation

hold

The proposal offers a premium, which is positive, but it is non-binding and subject to negotiation and approval by a special committee. The delisting and loss of liquidity are significant considerations. Therefore, a 'hold' recommendation is prudent, allowing investors to await further developments and the final terms of any potential transaction.

Keywords

going private, acquisition, consortium agreement, 111, Inc., delisting, NASDAQ, merger, shareholder proposal

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.